Victory Capital Management
CLDX icon

Victory Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$563K Buy
+27,650
New +$563K ﹤0.01% 2038
2025
Q1
Sell
-8,003
Closed -$202K 2484
2024
Q4
$202K Sell
8,003
-147
-2% -$3.72K ﹤0.01% 2233
2024
Q3
$277K Sell
8,150
-172
-2% -$5.85K ﹤0.01% 2154
2024
Q2
$308K Buy
8,322
+87
+1% +$3.22K ﹤0.01% 2093
2024
Q1
$346K Buy
8,235
+983
+14% +$41.3K ﹤0.01% 2077
2023
Q4
$288K Buy
+7,252
New +$288K ﹤0.01% 2139
2023
Q1
Sell
-5,096
Closed -$227K 2609
2022
Q4
$227K Sell
5,096
-6,673
-57% -$297K ﹤0.01% 2239
2022
Q3
$331K Sell
11,769
-6,918
-37% -$195K ﹤0.01% 2210
2022
Q2
$504K Buy
18,687
+1,263
+7% +$34.1K ﹤0.01% 2050
2022
Q1
$532K Buy
17,424
+1,935
+12% +$59.1K ﹤0.01% 2103
2021
Q4
$598K Sell
15,489
-4,188
-21% -$162K ﹤0.01% 2063
2021
Q3
$1.06M Sell
19,677
-3,456
-15% -$187K ﹤0.01% 1839
2021
Q2
$774K Sell
23,133
-3,632
-14% -$122K ﹤0.01% 1984
2021
Q1
$551K Buy
26,765
+10,012
+60% +$206K ﹤0.01% 2160
2020
Q4
$294K Buy
+16,753
New +$294K ﹤0.01% 2287
2020
Q2
Sell
-4,400
Closed -$8K 2657
2020
Q1
$8K Buy
+4,400
New +$8K ﹤0.01% 3354
2019
Q4
Sell
-1,796
Closed -$4K 2755
2019
Q3
$4K Buy
+1,796
New +$4K ﹤0.01% 3496
2017
Q2
Sell
-1,543
Closed -$6K 1812
2017
Q1
$6K Hold
1,543
﹤0.01% 1797
2016
Q4
$5K Buy
1,543
+86
+6% +$279 ﹤0.01% 1785
2016
Q3
$6K Buy
1,457
+97
+7% +$399 ﹤0.01% 1770
2016
Q2
$6K Buy
1,360
+26
+2% +$115 ﹤0.01% 1627
2016
Q1
$5K Buy
1,334
+105
+9% +$394 ﹤0.01% 1653
2015
Q4
$19K Buy
1,229
+66
+6% +$1.02K ﹤0.01% 1650
2015
Q3
$12K Buy
1,163
+103
+10% +$1.06K ﹤0.01% 1601
2015
Q2
$27K Buy
+1,060
New +$27K ﹤0.01% 1576